Learn More
Invitrogen™ Vimentin Monoclonal Antibody (SP20)

Description
Predicted to react with Rat, Hamster, Cow, and Xenopus laevis based on sequence homology. Recommended Postive Controls - WB: U-2 OS, Hu tonsil and HeLa cell lysates. Flow: HeLa cells. ICC/IF: HAP1-VIM cells, human limbal epithelial cells. IHC-P: Human breast cancer and melanoma tissue. IHC-Fr: Colorectal cancer tissue.
Specifications
Specifications
| Antigen | Vimentin |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | SP20 |
| Concentration | 0.006 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA and 0.1% sodium azide; pH 7.20 |
| Gene | Vim |
| Gene Accession No. | P08670, P20152 |
| Gene Alias | cb28; class-III intermediate microfilament; CTRCT30; epididymis luminal protein 113; FLJ36605; Hel113; intermediate filament; intermediate filament protein; RP11-124N14.1; similar to vimentin; VIM; VIME; Vimentin; vimentin C-terminus |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.